Aug. 26—Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray in the nose rather than a needle to the thigh. Last week the ...
Neffy, an epinephrine nasal spray designed to decrease severe allergic reactions and serve as an alternative to EpiPens, has officially been approved by the FDA, ARS Pharmaceuticals announced today in ...
A potentially ground-breaking nose-spray version of the drug epinephrine will soon hit the market — an alternative to auto-injectors like EpiPen for people having serious allergic reactions. The drug ...
On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor from ARS Pharma to older ...
WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and ...
Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use, which is critical in emergency situations such as an anaphylactic reaction. The ...
neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...
The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results